Peptides – Injectable Solutions
Peptides are compounded injectable treatments designed to support cellular repair, muscle development, fat reduction, and anti-aging benefits. These peptides target various systems including neurological, gastrointestinal, cardiovascular, and musculoskeletal health, enhancing overall wellness and recovery.
Protocols:
Injection Type
Intramuscular (IM) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
NAD+ (1000 mg /2ml Vial)
Dose (mg) | Units | Notes |
50 mg | 10 units | Starting dose |
100 mg | 20 units | Moderate dose |
150 mg | 30 units | Upper regular dose |
250 mg | 50 units | Maximum single dose |
Protocols:
Injection Type
Subcutaneous (SubQ) or Intramuscular (IM) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
BPC-157 5MG/2ML Vial
Dose (mg) | Insulin Units |
0.25 mg | 10 units |
0.375 mg | 15 units |
0.50 mg | 20 units |
0.625 mg | 25 units |
0.75 mg | 30 units |
Protocols:
1 vial lasts ~5 weeks at starting dose
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
CJC-1295 with DAC (10mg/1ml Vial)
Dose (mg) | Units | Notes |
2.0 mg | 20 units | Lower end of range |
3.0 mg | 30 units | Moderate dose |
4.0 mg | 40 units | Maximum weekly limit |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Ipamorelin 10MG/2ML Vial (0.05 mg per unit)
Dose (mcg) | Dose (mg) | Units |
200 mcg | 0.20 mg | 4 units |
250 mcg | 0.25 mg | 5 units |
300 mcg | 0.30 mg | 6 units |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Sermorelin 10MG/2ML Vial (0.05 mg per unit)
Dose (mcg) | Dose (mg) | Units |
500 mcg | 0.50 mg | 10 units |
1,000 mcg | 1.00 mg | 20 units |
1,500 mcg | 1.50 mg | 30 units |
2,000 mcg | 2.00 mg | 40 units |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Tesamorelin 10MG/1ML Vial
Dose (mg) | Units |
1.0 mg | 10 units |
1.5 mg | 15 units |
2.0 mg | 20 units |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
AOD-9604 6MG/6ML Vial (0.01 mg per unit)
Dose (mcg) | Dose (mg) | Units |
500 mcg | 0.50 mg | 50 units |
750 mcg | 0.75 mg | 75 units |
1,000 mcg | 1.00 mg | 100 units |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
AOD-9604 3MG/3ML Vial (0.01 mg per unit)
Dose (mcg) | Dose (mg) | Units |
500 mcg | 0.50 mg | 50 units |
750 mcg | 0.75 mg | 75 units |
1,000 mcg | 1.00 mg | 100 units |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Glow 42 mg / 3 mL Vial (0.14 mg per unit)
Dose (mcg) | Dose (mg) | Units |
900 mcg | 0.90 mg | 10 units |
1200 mcg | 1.20 mg | 14 units |
1800 mcg | 1.80 mg | 20 units |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using 1 mL / 100-unit insulin syringe)
Epitalon
(10mg/1ml Vial)
Dose (mg) | Units | Notes |
10 mg | 100 units | Full vial daily |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
Epitalon (50mg/2ml Vial)
Dose (mg) | Units | Notes |
10 mg | 40 units | Starting dose |
15 mg | 60 units | Moderate dose |
20 mg | 80 units | Maximum recommended dose |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
GHK-Cu (50mg/2ml vial)
Dose (mg) | Units | Notes |
1.0 mg | 4 units | Starting dose |
1.5 mg | 6 units | Moderate dose |
2.0 mg | 8 units | Maximum recommended dose |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
GHK-Cu (75mg/2ml Vial)
Dose (mg) | Units | Notes |
1.125 mg | 3 units | Starting dose |
1.50 mg | 4 units | Moderate dose |
1.875 mg | 5 units | Maximum recommended dose |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
GHK-Cu (100mg/3ml Vial)
Dose (mg) | Units | Notes |
0.99 mg | 3 units | Starting dose |
1.32 mg | 4 units | Moderate dose |
1.65 mg | 5 units | Upper moderate |
1.98 mg | 6 units | Maximum recommended dose |
Retatrutide – 6 Benefits
AOD 9604 – 6 Benefits
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
How to Increase the Dose (Titration Schedule)
(1 mL / 100-unit insulin syringe)
GLP-1 R (12mg/1.2ml vial)
Dose (mg) | Units | Notes |
2 mg | 20 units | Starting dose (Weeks 1–4) |
4 mg | 40 units | Step 2 (Weeks 5–8) |
6 mg | 60 units | Step 3 (Weeks 9–12) |
8 mg | 80 units | Step 4 (Weeks 13–16) |
10 mg | 100 units | Step 5 (Weeks 17–20) |
12 mg | 120 units | Maximum recommended dose |
(1 mL / 100-unit insulin syringe)
GLP-1 R (24mg/2.4ml vial):
Dose (mg) | Units | Notes |
2 mg | 20 units | Starting dose (Weeks 1–4) |
4 mg | 40 units | Step 2 (Weeks 5–8) |
6 mg | 60 units | Step 3 (Weeks 9–12) |
8 mg | 80 units | Step 4 (Weeks 13–16) |
10 mg | 100 units | Step 5 (Weeks 17–20) |
12 mg | 120 units | Maximum recommended dose |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
AOD-9604 6MG/6ML Vial (0.01 mg per unit)
Dose (mcg) | Dose (mg) | Units |
500 mcg | 0.50 mg | 50 units |
750 mcg | 0.75 mg | 75 units |
1,000 mcg | 1.00 mg | 100 units |
Ipamorelin – 6 Benefits
CJC-1295 w/ DAC – 6 Benefits
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Ipamorelin 10MG/2ML Vial (0.05 mg per unit)
Dose (mcg) | Dose (mg) | Units |
200 mcg | 0.20 mg | 4 units |
250 mcg | 0.25 mg | 5 units |
300 mcg | 0.30 mg | 6 units |
Protocols:
1 vial lasts ~5 weeks at starting dose
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
CJC-1295 with DAC (10mg/1ml Vial)
Dose (mg) | Units | Notes |
2.0 mg | 20 units | Lower end of range |
3.0 mg | 30 units | Moderate dose |
4.0 mg | 40 units | Maximum weekly limit |
Glow – 6 Benefits
Glutathione – 6 Benefits
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Glow 42 mg / 3 mL Vial (0.14 mg per unit)
Dose (mcg) | Dose (mg) | Units |
900 mcg | 0.90 mg | 10 units |
1200 mcg | 1.20 mg | 14 units |
1800 mcg | 1.80 mg | 20 units |
Epithalon – 6 Benefits
NAD+ – 6 Benefits
Protocols:
Injection Type
Intramuscular (IM) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
NAD+ (1000 mg /2ml Vial)
Dose (mg) | Units | Notes |
50 mg | 10 units | Starting dose |
100 mg | 20 units | Moderate dose |
150 mg | 30 units | Upper regular dose |
250 mg | 50 units | Maximum single dose |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
Epitalon (50mg/2ml Vial)
Dose (mg) | Units | Notes |
10 mg | 40 units | Starting dose |
15 mg | 60 units | Moderate dose |
20 mg | 80 units | Maximum recommended dose |
Glow – 6 Benefits
Ipamorelin – 6 Benefits
NAD+ – 6 Benefits
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Ipamorelin 10MG/2ML Vial (0.05 mg per unit)
Dose (mcg) | Dose (mg) | Units |
200 mcg | 0.20 mg | 4 units |
250 mcg | 0.25 mg | 5 units |
300 mcg | 0.30 mg | 6 units |
Protocols:
Injection Type
Intramuscular (IM) injection
Recommended Dose
Frequency
Dosing: (using a 1 mL / 100-unit insulin syringe)
NAD+ (1000 mg /2ml Vial)
Dose (mg) | Units | Notes |
50 mg | 10 units | Starting dose |
100 mg | 20 units | Moderate dose |
150 mg | 30 units | Upper regular dose |
250 mg | 50 units | Maximum single dose |
Protocols:
Injection Type
Subcutaneous (SubQ) injection
Recommended Dose
Frequency
Dosing:
Administered using a 1 mL (100-unit) insulin syringe
Glow 42 mg / 3 mL Vial (0.14 mg per unit)
Dose (mcg) | Dose (mg) | Units |
900 mcg | 0.90 mg | 10 units |
1200 mcg | 1.20 mg | 14 units |
1800 mcg | 1.80 mg | 20 units |
Targeted peptide combinations designed to help you achieve specific health, aesthetic, and performance goals.
————————–
Benefits:
Powerful GLP-1/GIP/glucagon agonist
Curbs appetite and reduces cravings
Promotes fat burning and weight loss
Dosing Schedule:
Dose: 2.5mg–5mg
Frequency: Once weekly
Timing: Any time of day
Method: Subcutaneous injection (abdomen or thigh)
Benefits:
Promotes lipolysis (fat breakdown), especially stubborn fat
Does not affect blood sugar or insulin
Aids in reducing body fat while preserving muscle
Dosing Schedule:
Dose: 300mcg
Frequency: Once or twice daily
Timing: Morning (and optionally evening) before meals or exercise
Method: Subcutaneous injection (abdomen)
————————–
Benefits:
Supports gut lining and digestive repair
Reduces gut inflammation
May improve metabolic and immune health
Dosing Schedule:
Dose: 250–500mcg
Frequency: Once or twice daily
Method: Subcutaneous injection (abdomen or near affected area)
————————–
Benefits:
Increases natural growth hormone (GH)
Supports fat burning
Improves sleep quality
Accelerates muscle recovery and lean muscle growth
Dosing Schedule:
Dose: 300mcg (CJC-1295 100mcg + Ipamorelin 200mcg)
Frequency: Once daily
Timing: At night, 30–60 minutes before bed
Method: Subcutaneous injection (stomach or outer thigh), on an empty stomach
Benefits:
Speeds up healing of muscles, tendons, and ligaments
Reduces inflammation
Helps prevent and treat sports-related injuries
Dosing Schedule:
Dose: 250–500mcg
Frequency: Once or twice daily (morning and night if treating an active injury)
Method: Subcutaneous injection near the injury site or in the stomach for systemic effect
————————–
Benefits:
Supports soft tissue repair and improves mobility
Enhances physical endurance
Aids in recovery from serious or chronic muscle injuries
Dosing Schedule:
Initial (loading) dose: 2–2.5mg, twice per week for 4–6 weeks
Maintenance: 2mg once every 1–2 weeks after loading phase
Method: Subcutaneous or intramuscular injection
————————–
Benefits:
Stimulates collagen and elastin
Improves skin glow and texture
Promotes wound healing and skin regeneration
Dosing Schedule:
Dose: 250–500mcg
Frequency: Once daily
Timing: Morning or evening
Method: Subcutaneous injection (can target skin or systemic)
Benefits:
Powerful antioxidant for skin and detox
Brightens complexion
Reduces oxidative stress
Dosing Schedule:
Dose: 600–1200mg
Frequency: 2–3x per week
Method: Intravenous (IV) or intramuscular injection
————————–
Benefits:
Boosts skin cell energy and DNA repair
Supports anti-aging at the cellular level
Improves texture, firmness, and radiance
Dosing Schedule:
Dose: 100–250mg
Frequency: 1–2x per week
Method: IV or subcutaneous injection
————————–
Benefits:
Supports telomere length and longevity
Regulates melatonin for better sleep
Activates anti-aging genes
Dosing Schedule:
Dose: 5–10mg
Frequency: Daily for 10–20 days (every 3–6 months as a cycle)
Method: Subcutaneous injection (abdomen or thigh)
Benefits:
Supports cellular energy (ATP production)
Enhances focus, memory, and mood
Repairs mitochondria and delays cellular aging
Dosing Schedule:
Dose: 100–250mg
Frequency: 1–2x per week
Method: IV infusion or subcutaneous injection
————————–
Benefits:
Supports immune system balance
Enhances tissue repair and regeneration
Complements Epitalon for longevity
Dosing Schedule:
Dose: 5–10mg
Frequency: Daily for 10–20 days
Method: Subcutaneous injection
————————–
Benefits:
Improves sleep, tone, and muscle recovery
Increases natural GH
Supports fat burning and anti-aging
Dosing Schedule:
Dose: 300mcg (CJC-1295 100mcg + Ipamorelin 200mcg)
Frequency: Once daily at night
Method: Subcutaneous injection
Benefits:
Skin rejuvenation, tissue repair, anti-aging
Enhances glow, reduces fine lines
Accelerates healing
Dosing Schedule:
Dose: 250–500mcg
Frequency: Once daily
Method: Subcutaneous injection
Benefits:
Boosts physical and mental energy
Repairs mitochondria
Enhances clarity, longevity, and anti-aging
Dosing Schedule:
Dose: 100–250mg
Frequency: 1–2x per week
Method: IV or subcutaneous injection
————————–
Benefits:
Powerful GLP-1/GIP/glucagon agonist
Curbs appetite and reduces cravings
Promotes fat burning and weight loss
Dosing Schedule:
Dose: 2.5mg–5mg
Frequency: Once weekly
Timing: Any time of day
Method: Subcutaneous injection (abdomen or thigh)
Benefits:
Supports telomere length and longevity
Regulates melatonin for better sleep
Activates anti-aging genes
Dosing Schedule:
Dose: 5–10mg
Frequency: Daily for 10–20 days (every 3–6 months as a cycle)
Method: Subcutaneous injection (abdomen or thigh)
You deserve to feel great about your appearance. At Botox And Filler Lab in Hallandale Beach, we use cutting-edge anti-aging treatments to help your face reflect your true self, whether in the mirror or photos. Schedule your consultation today and let us transform your look into a masterpiece you’ll love to share.
Leave your message, and we’ll get back to you shortly.